Inflammatory Bowel Disease

(asked on 24th March 2016) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, how much the NHS spent on treating people with inflammatory bowel disease in (a) the last 12 months and (b) each of the last five financial years.


Answered by
 Portrait
Jane Ellison
This question was answered on 11th April 2016

The information is not available in the format requested.

Such information as is available on the cost to the National Health Service of treating inflammatory bowel disease is from reference costs, which are the average unit cost to NHS hospital trusts of providing defined services to patients in a given financial year. Reference costs for acute care are collected by Healthcare Resource Group (HRG), a secondary classification system which groups similar treatments that use similar resources. Reference costs are published annually, most recently for 2014-15.

The following table reflects the costs of treating patients who are admitted to hospital and does not include the treatment of inflammatory bowel disease in outpatient or other settings outside of hospital. The costs are not comparable between years because of changes to the HRG design and to the underlying primary classification system for diseases.

Estimated total costs (£millions) to NHS hospitals of treating inflammatory bowel disease, 2010-11 to 2014-15

2010-11

2011-12

2012-13

2013-14

2014-15

Inflammatory bowel disease

207.3

147.1

73.0

78.8

82.9

Paediatric inflammatory bowel disease

12.1

8.4

9.7

10.6

10.9

Total

219.4

155.5

82.6

89.5

93.8

Source: Reference costs, Department of Health

Notes:

  1. For each HRG or other currency in the reference cost collection, NHS hospital trusts submit a unit cost and amount of activity undertaken.
  2. Costs are not comparable between years:
    1. changes to the HRG design in 2011-12 resulted in the removal of HRGs specific to procedures for inflammatory bowel disease. These costs are included in other HRGs and are no longer separately identifiable.
    2. revised clinical coding guidance introduced in 2012-13 with the International Classification of Diseases 10th revision (ICD-10), fourth edition, resulted in the transfer of significant activity (and therefore costs) associated with infectious gastroenteritis and colitis to other HRGs.
  3. The following HRGs are included in the table:

2010-11

FZ37F Inflammatory Bowel Disease with length of stay 1 day or less

FZ37G Inflammatory Bowel Disease with length of stay 2 days or more with Major Complications and Comorbidities (CC) with Interventions

FZ37H Inflammatory Bowel Disease with length of stay 2 days or more with Major CC without Interventions

FZ37I Inflammatory Bowel Disease with length of stay 2 days or more without Major CC with Interventions

FZ37J Inflammatory Bowel Disease with length of stay 2 days or more without Major CC without Interventions

FZ14Z Complex Procedures for Inflammatory Bowel Disease

FZ15Z Major Procedures for Inflammatory Bowel Disease

FZ28A Endoscopic or Intermediate Procedures for Inflammatory Bowel Disease 19 years and over with CC

FZ28B Endoscopic or Intermediate Procedures for Inflammatory Bowel Disease 19 years and over without CC

FZ28C Endoscopic or Intermediate Procedures for Inflammatory Bowel Disease 18 years and under

PA27Z Inflammatory Bowel Disease

2011-12

FZ37F Inflammatory Bowel Disease with length of stay 1 day or less

FZ37G Inflammatory Bowel Disease with length of stay 2 days or more with Major CC with Interventions

FZ37H Inflammatory Bowel Disease with length of stay 2 days or more with Major CC without Interventions

FZ37I Inflammatory Bowel Disease with length of stay 2 days or more without Major CC with Interventions

FZ37J Inflammatory Bowel Disease with length of stay 2 days or more without Major CC without Interventions

PA27Z Inflammatory Bowel Disease

2012-13

FZ37K Inflammatory Bowel Disease with Multiple Interventions, with CC Score 3+

FZ37L Inflammatory Bowel Disease with Multiple Interventions, with CC Score 0-2

FZ37M Inflammatory Bowel Disease with Single Intervention, with CC Score 4+

FZ37N Inflammatory Bowel Disease with Single Intervention, with CC Score 0-3

FZ37P Inflammatory Bowel Disease without Interventions, with CC Score 5+

FZ37Q Inflammatory Bowel Disease without Interventions, with CC Score 3-4

FZ37R Inflammatory Bowel Disease without Interventions, with CC Score 1-2

FZ37S Inflammatory Bowel Disease without Interventions, with CC Score 0

PA27Z Inflammatory Bowel Disease

2013-14 and 2014-15

FZ37K Inflammatory Bowel Disease with Multiple Interventions, with CC Score 3+

FZ37L Inflammatory Bowel Disease with Multiple Interventions, with CC Score 0-2

FZ37M Inflammatory Bowel Disease with Single Intervention, with CC Score 4+

FZ37N Inflammatory Bowel Disease with Single Intervention, with CC Score 0-3

FZ37P Inflammatory Bowel Disease without Interventions, with CC Score 5+

FZ37Q Inflammatory Bowel Disease without Interventions, with CC Score 3-4

FZ37R Inflammatory Bowel Disease without Interventions, with CC Score 1-2

FZ37S Inflammatory Bowel Disease without Interventions, with CC Score 0

PF27A Paediatric Inflammatory Bowel Disease with CC Score 1+

PF27B Paediatric Inflammatory Bowel Disease with CC Score 0

Reticulating Splines